Effect of diaspirin crosslinked and stroma-reduced hemoglobin on mean arterial pressure and endothelin-1 concentration in rats.

[1]  S. Rebello,et al.  Role of adrenergic mechanisms in the pressor effect of diaspirin cross-linked hemoglobin. , 1994, The Journal of laboratory and clinical medicine.

[2]  Y. Ouchi,et al.  Elevated blood pressure and craniofaclal abnormalities in mice deficient in endothelin-1 , 1994, Nature.

[3]  A. Gulati,et al.  Effect of diaspirin cross-linked hemoglobin and norepinephrine on systemic hemodynamics and regional circulation in rats. , 1994, The Journal of laboratory and clinical medicine.

[4]  K. Burhop,et al.  A role for endothelin and nitric oxide in the pressor response to diaspirin cross-linked hemoglobin. , 1993, The Journal of laboratory and clinical medicine.

[5]  W. Kuschinsky,et al.  [Modified hemoglobin as a blood substitute in a rat model]. , 1993, Der Anaesthesist.

[6]  H. Bunn The use of hemoglobin as a blood substitute , 1993, American journal of hematology.

[7]  J. Lundberg,et al.  Free haemoglobin interferes with detection of endothelin peptides. , 1992, Biochemical and biophysical research communications.

[8]  G. Berbers,et al.  Detection of erythrocyte membrane components in hemoglobin-based blood substitutes. , 1992, Clinica chimica acta; international journal of clinical chemistry.

[9]  E. Ohlstein,et al.  Oxyhemoglobin stimulation of endothelin production in cultured endothelial cells. , 1992, Journal of neurosurgery.

[10]  J. Angus,et al.  Oxyhaemoglobin increases the production of endothelin-1 by endothelial cells in culture. , 1991, European journal of pharmacology.

[11]  Malcolm Ds,et al.  Cross-linked hemoglobin solution as a resuscitative fluid after hemorrhage in the rat. , 1991 .

[12]  T. Sakurai,et al.  Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor , 1990, Nature.

[13]  S. Nakanishi,et al.  Cloning and expression of a cDNA encoding an endothelin receptor , 1990, Nature.

[14]  Kitazumi Kazuhiro,et al.  Vasodilator effects of sarafotoxins and endothelin-1 in spontaneously hypertensive rats and rat isolated perfused mesentery , 1990 .

[15]  Y. Sugishita,et al.  Characteristics of Pressor Response to Endothelin in Spontaneously Hypertensive and Wistar‐Kyoto Rats , 1989, Hypertension.

[16]  H. Lippton,et al.  Effects of endothelin in the systemic and renal vascular beds in vivo. , 1988, European journal of pharmacology.

[17]  J. Fozard,et al.  Regional vasodilation is a prominent feature of the haemodynamic response to endothelin in anaesthetized, spontaneously hypertensive rats. , 1988, European journal of pharmacology.

[18]  W. Odling‐Smee,et al.  Detection of a vasoconstrictor factor in stroma-free haemoglobin solutions. , 1988, The Journal of trauma.

[19]  P. Rogers,et al.  Isolation and characterization of a new hemoglobin derivative cross-linked between the alpha chains (lysine 99 alpha 1----lysine 99 alpha 2). , 1986, The Journal of biological chemistry.

[20]  K. Messmer,et al.  Oxygen‐transporting fluids and oxygen delivery with hemodilution , 1982, Critical care medicine.

[21]  J. Arnold,et al.  A clinical safety trial of stroma‐free hemoglobin , 1978, Clinical pharmacology and therapeutics.

[22]  J. Helbert,et al.  EVALUATION OF A STROMA-FREE HEMOGLOBIN SOLUTION FOR USE AS A PLASMA EXPANDER , 1967, The Journal of experimental medicine.

[23]  E. Thompson,et al.  Renal endothelin mechanism in altered thyroid states. , 1994, Life sciences.

[24]  A. Gulati,et al.  Endothelin mechanisms in the central nervous system: A target for drug development , 1992 .

[25]  H. Lippton,et al.  Hemodynamic and pharmacological evaluation of the vasodilator and vasoconstrictor effects of endothelin-1 in rats. , 1990, The Journal of pharmacology and experimental therapeutics.